CoreCap Advisors’s Apogee Therapeutics APGE Stock Holding History

CoreCap Advisors’s Portfolio APGE Stock Details APGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	–	Sell	-2	Closed	-$265	–	3153
2026 Q2	$265	Buy	+2	New	+$180	﹤0.01%	2971

Other funds holding APGE

IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return

CoreCap Advisors's APGE Position: Q3 2026 in Review

CoreCap Advisors sold out of Apogee Therapeutics (APGE) in Q3 2026, closing a stake of 2 shares — an estimated $265 sold.

CoreCap Advisors first reported a position in APGE in Q2 2026 and held it in 1 quarter. The position peaked at $265 in Q2 2026. 1 fund tracked by Wall St. Rank holds APGE as of Q3 2026.

CoreCap Advisors reported no remaining Apogee Therapeutics position as of Q3 2026 after selling out during the quarter.
CoreCap Advisors sold 2 Apogee Therapeutics shares in Q3 2026, an estimated $265.
CoreCap Advisors first reported a position in Apogee Therapeutics in Q2 2026 and held it in 1 quarter.
CoreCap Advisors's Apogee Therapeutics position peaked at $265 in Q2 2026.
1 fund tracked by Wall St. Rank held Apogee Therapeutics as of Q3 2026.

Based on CoreCap Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.